Unlike drugs, active implants such as electroceuticals act locally, have fewer side effects and function directly through electrical signals, much like the body itself. Fraunhofer researchers presenting a new technology platform that can power active implants wirelessly via ultrasound. The experts are targeting widespread diseases such as high blood pressure, diabetes and Parkinson's.
DGIST Professor Hongsoo Choi (Department of Robotics Engineering) and his research team developed the world's first artificial basilar membrane that mimics the cochlear function by application of the genetic principle of frictional electricity.
Serotonin is a neurotransmitter that's partly responsible for feelings of happiness and for mood regulation in humans. This makes it a common target for antidepressants, which block serotonin from being reabsorbed by neurons after it has dispatched its signal, so more of it stays floating around the brain.
A diagnosis of pancreatic cancer is often a death sentence because chemotherapy and radiation have little impact on the disease. In the U.S. this year, some 53,000 new cases will be diagnosed, and 42,000 patients will die of the disease. But research now being reported in ACS Nano could eventually lead to a new type of treatment based on gold nanoparticles.
Washington State University researchers have developed a low-cost, portable laboratory on a smartphone that can analyze several samples at once to catch a cancer biomarker, producing lab quality results.
A new imaging method, called "polarized nuclear imaging" - combining aspects of both magnetic resonance imaging and gamma-ray imaging - has potential for new types of high-resolution medical diagnostics as well as industrial and physics research applications.
'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory.
New large steam sterilisers add a 'fourth dimension to reprocessing' Gütersloh/Düsseldorf, October 24, 2016. – Visitors to Miele Professional's stand at Medica are set to experience a new dimension in...
Bedfont® Scientific, Kent, launches their new GastroCH4ECK™ Gastrolyzer® at the United European Gastroenterology Week 2016 Bedfont® Scientific has specialised in the design and manufacture of exhaled...
Kinestica has been awarded by SME instrument grant to introduce Homer – a project aiming to develop affordable and widely accessible home rehabilitation system. By ranking among top 5 % of the EU SMEs...
Mini-Multiplace Hyperbaric Chamber Model: OXYLIFE C Modular construction Relative ease of assembly and disassembly, Portability and installation without building, doorway modification. The 3 sections...
Imagine being able to think, hear, and feel - but not move or communicate. Over 40% of patients diagnosed as vegetative are reclassified as (at least) minimally conscious when assessed by expert teams.
Image: MRI-pictures of a brain. Left, a hand, holding a pen, pointing at an MRI-picture; Copyright: panthermedia.net/olegdudko
Contrast agents improve the imaging of tissue made by MRI and thus are essential for getting more detailed imaging. But commonly used contrast agents, that are usually based on the metal gadolinium, cannot show enough contrast in early stage of diseases without increasing their concentration up to high levels.
The trend towards miniaturization is progressing in medical technology. This in turn also means that electronics must be adapted to size relations, for example of implants. Smaller structures and components are in demand as never before. Thus, the demands on the technology and production simultaneously grow.